3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
27
Anemia, Refractory, with Excess of Blasts
27
Myelodysplastic Syndromes
22
Myeloproliferative Disorders
14
Venous Thromboembolism
13
Precursor Cell Lymphoblastic Leukemia-Lymphoma
13
Neoplasms
11
Lymphoma, Non-Hodgkin
11
Leukemia, Myelomonocytic, Chronic
10
Anemia
10
Primary Myelofibrosis
9
Hematologic Neoplasms
9
Anemia, Aplastic
9
Leukemia, Lymphocytic, Chronic, B-Cell
8
Hodgkin Disease
8
Thrombocytopenia
7
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
7
Leukemia
7
Fanconi Anemia
7
Multiple Myeloma
6
Congenital Bone Marrow Failure Syndromes
6
Venous Thrombosis
5
Pulmonary Embolism
5
Myelodysplastic-Myeloproliferative Diseases
5
Lymphoma, Follicular
5
Febrile Neutropenia
5
Anemia, Sickle Cell
5
Recurrence
4
Leukemia, Myeloid, Accelerated Phase
4
Leukemia, Biphenotypic, Acute
4
Interventions
edoxaban
1
apixaban
1
Rivaroxaban
1
Heparin, Low-Molecular-Weight
1
Dabigatran
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Embolism
×
Classical hematology
×
90 days
×
Clear all
NCT04618913
2026-05-26
VICTORIE
Pfizer
Active not recruiting
1 enrolled